TEXAS PERMANENT SCHOOL FUND CORP - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 168 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TEXAS PERMANENT SCHOOL FUND CORP ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$264,919
+131048.0%
9,338
+35.0%
0.00%0.0%
Q4 2022$202
-99.9%
6,916
-9.6%
0.00%0.0%
Q3 2022$202,000
-43.9%
7,648
-5.6%
0.00%
-50.0%
Q2 2022$360,000
-9.8%
8,100
+0.5%
0.01%
+20.0%
Q1 2022$399,000
-4.3%
8,057
-1.6%
0.01%0.0%
Q4 2021$417,000
-12.4%
8,192
-3.9%
0.01%
-16.7%
Q3 2021$476,000
+28.0%
8,526
-1.9%
0.01%
+50.0%
Q2 2021$372,000
+2.8%
8,695
+0.4%
0.00%0.0%
Q1 2021$362,000
-16.6%
8,664
-7.0%
0.00%
-20.0%
Q4 2020$434,000
-9.6%
9,312
-17.6%
0.01%
-16.7%
Q3 2020$480,000
+25.0%
11,304
+41.3%
0.01%0.0%
Q2 2020$384,000
-2.0%
8,001
-6.2%
0.01%
-14.3%
Q1 2020$392,000
-5.8%
8,527
+23.2%
0.01%
+16.7%
Q4 2019$416,000
+6.9%
6,920
+0.5%
0.01%0.0%
Q3 2019$389,0000.0%6,884
-1.6%
0.01%0.0%
Q2 2019$389,000
+10.2%
6,993
-0.0%
0.01%0.0%
Q1 2019$353,000
+21.7%
6,996
-2.8%
0.01%
+20.0%
Q4 2018$290,000
-40.3%
7,197
+2.7%
0.01%
-28.6%
Q3 2018$486,000
+19.7%
7,010
+30.5%
0.01%
+16.7%
Q2 2018$406,000
+39.5%
5,372
-2.9%
0.01%
+50.0%
Q1 2018$291,000
-3.6%
5,532
-2.1%
0.00%0.0%
Q4 2017$302,000
-18.6%
5,649
-9.3%
0.00%
-20.0%
Q3 2017$371,000
-17.4%
6,225
+9.3%
0.01%
-16.7%
Q2 2017$449,000
-7.8%
5,696
-2.9%
0.01%0.0%
Q1 2017$487,000
+6.8%
5,867
+2.2%
0.01%0.0%
Q4 2016$456,000
+7.3%
5,742
-5.5%
0.01%0.0%
Q3 2016$425,0006,0750.01%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 121,014$5,377,0001.78%
Smith, Graham & Co., Investment Advisors, LP 232,343$10,323,0001.28%
GLOBEFLEX CAPITAL L P 73,205$3,252,0000.79%
SummerHaven Investment Management, LLC 18,604$827,0000.56%
BRANDES INVESTMENT PARTNERS, LP 464,292$20,628,0000.50%
Capital Impact Advisors, LLC 11,728$521,0000.48%
Watershed Asset Management, L.L.C. 5,756$256,0000.32%
Foundry Partners, LLC 84,325$3,747,0000.23%
Summit Global Investments 33,738$1,499,0000.13%
SCOUT INVESTMENTS, INC. 147,034$6,533,0000.13%
View complete list of EAGLE PHARMACEUTICALS INC shareholders